172 related articles for article (PubMed ID: 31614132)
1. AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer.
Li J; Hu J; Luo Z; Zhou C; Huang L; Zhang H; Chi J; Chen Z; Li Q; Deng M; Chen J; Tao K; Wang G; Wang L; Wang Z
Exp Cell Res; 2019 Dec; 385(1):111644. PubMed ID: 31614132
[TBL] [Abstract][Full Text] [Related]
2. Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H; Chi J; Hu J; Ji T; Luo Z; Zhou C; Huang L; Dai Z; Li J; Wang G; Wang L; Wang Z
Cancer Lett; 2021 Oct; 518():180-195. PubMed ID: 34216690
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.
Lin J; Shi Z; Yu Z; He Z
Biomed Pharmacother; 2018 Feb; 98():433-439. PubMed ID: 29278853
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
Li J; Song P; Jiang T; Dai D; Wang H; Sun J; Zhu L; Xu W; Feng L; Shin VY; Morrison H; Wang X; Jin H
Mol Ther; 2018 Jul; 26(7):1828-1839. PubMed ID: 29730197
[TBL] [Abstract][Full Text] [Related]
5. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
[TBL] [Abstract][Full Text] [Related]
6. Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt11-mediated non-canonical Wnt signaling.
Tian S; Hu J; Tao K; Wang J; Chu Y; Li J; Liu Z; Ding X; Xu L; Li Q; Cai M; Gao J; Shuai X; Wang G; Wang L; Wang Z
Exp Cell Res; 2018 Mar; 364(2):198-207. PubMed ID: 29427622
[TBL] [Abstract][Full Text] [Related]
7. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
8. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
To KK; Leung WW; Ng SS
Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
[TBL] [Abstract][Full Text] [Related]
9. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.
Sung HY; Choi EN; Lyu D; Park AK; Ju W; Ahn JH
Oncol Rep; 2014 Aug; 32(2):815-20. PubMed ID: 24920423
[TBL] [Abstract][Full Text] [Related]
10. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.
Dahal Lamichane B; Jung SY; Yun J; Kang S; Kim DY; Lamichane S; Kim YJ; Park JH; Jang WB; Ji ST; Dehua L; Ha JS; Kim YH; Kwon SM
Biochem Biophys Res Commun; 2019 Aug; 515(4):600-606. PubMed ID: 31178140
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.
Zhang L; Tian S; Pei M; Zhao M; Wang L; Jiang Y; Yang T; Zhao J; Song L; Yang X
Oncol Rep; 2019 Dec; 42(6):2655-2669. PubMed ID: 31661141
[TBL] [Abstract][Full Text] [Related]
13. Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells.
Yang SM; Li SY; Yu HB; Li JR; Sun LL
Biomed Pharmacother; 2017 Jun; 90():93-99. PubMed ID: 28343076
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
Liu T; Wu X; Chen T; Luo Z; Hu X
Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
[No Abstract] [Full Text] [Related]
16. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Li J; Su X; Dai L; Chen N; Fang C; Dong Z; Fu J; Yu Y; Wang W; Zhang H; Wang H; Ji Y; Liu Y; Cheng L; Shi G; Zhang S; Yang Y; Deng H
Carcinogenesis; 2020 Apr; 41(2):235-244. PubMed ID: 31802101
[TBL] [Abstract][Full Text] [Related]
17. Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer.
Jung SY; Yun J; Kim SJ; Kang S; Kim DY; Kim YJ; Park JH; Jang WB; Ji ST; Ha JS; Hong Van LT; Truong Giang LT; Rethineswaran VK; Kim DH; Song P; Kwon SM
Biochem Biophys Res Commun; 2019 Aug; 516(1):149-156. PubMed ID: 31202462
[TBL] [Abstract][Full Text] [Related]
18. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
González B; Fece de la Cruz F; Samuelsson JK; Alibés A; Alonso S
Sci Rep; 2018 Jul; 8(1):11097. PubMed ID: 30038405
[TBL] [Abstract][Full Text] [Related]
20. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Kim JT; Weiss HL; Evers BM
Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
